Drug Shortage Report for DDAVP SPRAY
Report ID | 119947 |
Drug Identification Number | 00836362 |
Brand name | DDAVP SPRAY |
Common or Proper name | desmopressin acetate nasal solution |
Company Name | FERRING INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | DESMOPRESSIN ACETATE |
Strength(s) | 10MCG |
Dosage form(s) | METERED-DOSE AEROSOL |
Route of administration | NASAL NASAL |
Packaging size | 5.0 mL |
ATC code | H01BA |
ATC description | POSTERIOR PITUITARY LOBE HORMONES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-07-07 |
Estimated end date | |
Actual end date | 2020-07-14 |
Shortage status | Resolved |
Updated date | 2020-07-15 |
Company comments | Product has been discontinued on July 14, 2020 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 200 YORKLAND BLVD TORONTO, ONTARIO CANADA M2J 5C1 |
Company contact information | 1-800-263-4057 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2020-07-15 | English | Compare |
v5 | 2020-07-14 | French | Compare |
v4 | 2020-07-14 | English | Compare |
v3 | 2020-07-14 | English | Compare |
v2 | 2020-07-10 | French | Compare |
v1 | 2020-07-10 | English | Compare |
Showing 1 to 6 of 6